Skandinaviska Enskilda Banken AB publ trimmed its position in The Clorox Company (NYSE:CLX – Free Report) by 67.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,913 shares of the company’s stock after selling 54,550 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Clorox were worth $3,195,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in CLX. denkapparat Operations GmbH lifted its holdings in Clorox by 301.6% in the third quarter. denkapparat Operations GmbH now owns 7,630 shares of the company’s stock valued at $941,000 after acquiring an additional 5,730 shares during the last quarter. Tobam raised its position in Clorox by 11.3% in the third quarter. Tobam now owns 54,281 shares of the company’s stock valued at $6,693,000 after purchasing an additional 5,497 shares during the period. Eagle Rock Investment Company LLC raised its position in Clorox by 17.2% in the third quarter. Eagle Rock Investment Company LLC now owns 35,430 shares of the company’s stock valued at $4,369,000 after purchasing an additional 5,196 shares during the period. Fifth Third Bancorp lifted its stake in shares of Clorox by 5.2% in the 3rd quarter. Fifth Third Bancorp now owns 4,852 shares of the company’s stock valued at $598,000 after purchasing an additional 239 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Clorox by 27.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after purchasing an additional 197,330 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.
More Clorox News
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Zacks raised its FY2028 EPS view to $7.23 and upgraded select quarterly/annual estimates (including Q1 2028 to $1.37 and Q4 2026/2027 increases), signaling modestly better forward earnings visibility that can support the stock.
- Positive Sentiment: Clorox published a consumer research report “Home Care Redefined” that underscores evolving demand for wellness- and convenience-oriented home-care products — a strategic tailwind for branded consumer staples. Home Care Redefined
- Neutral Sentiment: Management presented at the Consumer Analyst Group of New York (CAGNY) conference; slides and prepared remarks provide more detail on strategy, cost actions and growth initiatives — useful for longer-term positioning but not an immediate earnings surprise. CAGNY Slides Transcript
- Negative Sentiment: Zacks trimmed multiple near-term quarterly EPS forecasts (several Q2–Q3 2026/2027 cuts and FY2027 lowered to $6.74), reflecting caution about near-term volume/mix or cost pressure — a potential headwind for sentiment and short-term guidance expectations.
- Negative Sentiment: Wells Fargo issued a “Hold” on CLX (reported as “receives a Hold”), which keeps sell-side sentiment neutral-to-cautious and may limit near-term upside from upgrades. Wells Fargo Hold
Wall Street Analyst Weigh In
View Our Latest Analysis on Clorox
Clorox Price Performance
Shares of CLX opened at $123.51 on Friday. The company has a market cap of $14.93 billion, a P/E ratio of 20.18, a PEG ratio of 0.60 and a beta of 0.59. The Clorox Company has a fifty-two week low of $96.66 and a fifty-two week high of $159.04. The company has a quick ratio of 0.48, a current ratio of 0.74 and a debt-to-equity ratio of 71.03. The firm’s 50 day moving average price is $109.75 and its 200 day moving average price is $113.68.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $1.39 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm earned $1.55 EPS. The business’s revenue was down .8% on a year-over-year basis. On average, research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
About Clorox
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Featured Articles
- Five stocks we like better than Clorox
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
